These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 14971062)

  • 21. Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States.
    Nemeroff CB; Kalali A; Keller MB; Charney DS; Lenderts SE; Cascade EF; Stephenson H; Schatzberg AF
    Arch Gen Psychiatry; 2007 Apr; 64(4):466-72. PubMed ID: 17404123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Publication bias and the efficacy of antidepressants.
    Mathew SJ; Charney DS
    Am J Psychiatry; 2009 Feb; 166(2):140-5. PubMed ID: 19188290
    [No Abstract]   [Full Text] [Related]  

  • 23. Manufacturer admits increase in suicidal behaviour in patients taking paroxetine.
    Lenzer J
    BMJ; 2006 May; 332(7551):1175. PubMed ID: 16709983
    [No Abstract]   [Full Text] [Related]  

  • 24. FDA to review risks of antidepressants in adults.
    Lenzer J
    BMJ; 2004 Oct; 329(7470):816. PubMed ID: 15472244
    [No Abstract]   [Full Text] [Related]  

  • 25. Reversible paroxetine-induced symptomatic hypothyroidism.
    Takahashi M; Sawayama E; Sawayama T; Miyaoka H
    Pharmacopsychiatry; 2007 Sep; 40(5):201-2. PubMed ID: 17874352
    [No Abstract]   [Full Text] [Related]  

  • 26. Antidepressant use in children.
    FDA Consum; 2004; 38(1):3. PubMed ID: 15032181
    [No Abstract]   [Full Text] [Related]  

  • 27. Psychopharmacology. Study questions antidepressant risks.
    Couzin J
    Science; 2007 Apr; 316(5823):354. PubMed ID: 17446361
    [No Abstract]   [Full Text] [Related]  

  • 28. FDA again reviews antidepressants.
    Tanne JH
    BMJ; 2004 Aug; 329(7464):475. PubMed ID: 15331461
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparison study of venlafaxine and paroxetine for the treatment of depression in elderly Chinese inpatients.
    Hwang JP; Yang CH; Tsai SJ
    Int J Geriatr Psychiatry; 2004 Feb; 19(2):189-90. PubMed ID: 14758586
    [No Abstract]   [Full Text] [Related]  

  • 30. Congress investigates FDA's handling of antidepressant safety information.
    Young D
    Am J Health Syst Pharm; 2004 Nov; 61(21):2228, 2230, 2232 passim. PubMed ID: 15552624
    [No Abstract]   [Full Text] [Related]  

  • 31. Withdrawal from paroxetine can be severe, warns FDA.
    Tonks A
    BMJ; 2002 Feb; 324(7332):260. PubMed ID: 11823353
    [No Abstract]   [Full Text] [Related]  

  • 32. Data mining approach shows promise in detecting unexpected drug interactions.
    Hampton T
    JAMA; 2011 Jul; 306(2):144. PubMed ID: 21750287
    [No Abstract]   [Full Text] [Related]  

  • 33. From the editor--drug companies under investigation.
    Thomas SP
    Issues Ment Health Nurs; 2004 Dec; 25(8):751-2. PubMed ID: 15545240
    [No Abstract]   [Full Text] [Related]  

  • 34. Finding studies on reboxetine: a tale of hide and seek.
    Wieseler B; McGauran N; Kaiser T
    BMJ; 2010 Oct; 341():c4942. PubMed ID: 20940211
    [No Abstract]   [Full Text] [Related]  

  • 35. Caution over antidepressants may have backfired.
    Wallis L
    Am J Nurs; 2014 Sep; 114(9):16. PubMed ID: 25166232
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Digitalis intoxication induced by paroxetine co-administration.
    Yasui-Furukori N; Kaneko S
    Lancet; 2006 Mar; 367(9512):788. PubMed ID: 16517279
    [No Abstract]   [Full Text] [Related]  

  • 37. FDA warns that antidepressants may increase suicidality in adults.
    Lenzer J
    BMJ; 2005 Jul; 331(7508):70. PubMed ID: 16002878
    [No Abstract]   [Full Text] [Related]  

  • 38. Suicidality in adolescents being treated with antidepressant medications and the black box label: position paper of the Society for Adolescent Medicine.
    Lock J; Walker LR; Rickert VI; Katzman DK;
    J Adolesc Health; 2005 Jan; 36(1):92-3. PubMed ID: 15702497
    [No Abstract]   [Full Text] [Related]  

  • 39. Serum levels of substance P and response to antidepressant pharmacotherapy.
    Lieb K; Walden J; Grunze H; Fiebich BL; Berger M; Normann C
    Pharmacopsychiatry; 2004 Sep; 37(5):238-9. PubMed ID: 15470802
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Toxic hepatitis associated with paroxetine.
    Colakoglu O; Tankurt E; Unsal B; Ugur F; Kupelioglu A; Buyrac Z; Akpinar Z
    Int J Clin Pract; 2005 Jul; 59(7):861-2. PubMed ID: 15963219
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.